High-Flying Biotech Stock 360% Faces Trim, Top Holding
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Choosing retirement options involves several important factors. Learn what to consider to ensure a comfortable and secure retirement.
19,521 articlesA biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Microsoft has faced a sharp pullback as AI spending and cloud dynamics shift. This article weighs the risks and oppor...
When AI dominates headlines, investors often fear every software stock will crumble. This piece digs into whether fig...
Robinhood just announced a substantial $1.5 billion buyback. In this analysis, we weigh the potential benefits agains...
After years of outsized gains, the magnificent seven faces a pullback. This guide explains how to evaluate the dip, p...
Lilly stock has faced pressure, but one key driver could keep it in buy territory. This article unpacks the core reas...
A Nurix Therapeutics insider recently sold shares, drawing attention from investors. This article breaks down the mov...
As EPR Properties gears up for its 2026 earnings call, investors will scrutinize tenant mix, attendance trends, and c...
As Republic Services reveals Q1 2026 figures, investors gain a window into revenue growth, margins, and cash flow. Th...
Palantir stock has captured attention as market conditions shift and AI headlines rise. This guide breaks down what’s...
A single fund's exit from Klaviyo set off a ripple effect that shaved a chunk from the stock after earnings. This art...
Celsius shares have fallen more than 50% from their intraday peaks as growth from newly acquired brands accelerates. ...